Bristol Myers Squibb (BMY)

CapEx to Revenue

2.35%

Quarterly · Period ending:

BMY logo

BMY CapEx to Revenue

Latest reported2.35%
BMY Quarterly CapEx/Revenue (0.00% → 2.35%)
High-resolution chart · PNG

BMY capex to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Bristol Myers Squibb CapEx to Revenue — Quarterly
Period endingCapEx to Revenue
2.351%
3.0203%
2.9593%
2.6182%
2.9424%
2.3212%
3.0627%
2.7245%
2.1474%
2.3936%
2.8753%
3.1187%
2.3071%
2.4521%
3.0335%
2.2018%
2.2882%
2.172%
2.67%
2.3228%
1.7944%
1.5624%
2.5569%
1.4516%
1.2933%
1.7253%
3.1592%
3.163%
3.0448%
3.4459%
4.8552%
3.936%
3.4712%
4.6023%
4.6614%
4.9867%
4.8212%
5.9038%
7.0761%
6.9281%
5.3582%
5.5113%
6.648%
5.7508%
3.9635%
3.3655%
4.4857%
2.7289%
2.8285%
3.0963%
4.5035%
3.0504%
2.4209%
3.0018%
4.1756%
3.667%
2.5433%
2.3424%
2.4569%
1.5716%
1.3618%
1.4967%
2.4457%
1.8549%
1.6988%
2.6836%
6.7077%
3.08%
3.0461%
4.008%
5.4296%
3.7305%
4.0361%
4.8253%
5.1083%
3.6634%
4.1802%
4.513%
5.3643%
4.8146%
3.3874%
4.3199%
4.0048%
3.9018%
4.0499%
3.9938%
6.0742%
5.5832%
2.5783%
3.1461%
7.8012%
4.6281%
3.9786%
4.5213%
5.9032%
5.2237%
6.563%
5.169%
6.3612%
5.8191%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.